Drugs could still be costly under World Trade Organization dealBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7416.639 (Published 18 September 2003) Cite this as: BMJ 2003;327:639
- Fiona Fleck
A landmark deal that allows poor countries without any manufacturing capability of their own to waive international trade rules and import cheap copies of patented drugs is likey to be a complex procedure that may not reduce prices enough, experts say.
UN secretary general Kofi Annan issued a statement to the World Trade Organization meeting in Cancun, Mexico, last week, after the deal was clinched in Geneva, saying that it was a “moral imperative” for each of the organisation's 146 member countries to implement …
Log in using your username and password
Log in through your institution
Sign up for a free trial